Sage Journals: Discover world-class research

Open access

Research article

First published 2023-05

Complement system in Anti-CD20 mAb therapy for cancer: A mini-review

Yiwen Gao

International Journal of Immunopathology and Pharmacology

Open access

Research article

First published 2026-1

Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis – A meta-analysis

Mahmoud Elkhooly, Rhea Jacob, Torge Rempe

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2021-12

Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis

Quentin Howlett-Prieto, Xuan Feng, John F Kramer [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2017

Anti-CD20 Cell Therapies in Multiple Sclerosis—A Fixed Dosing Schedule for Ocrelizumab is Overkill

Jagannadha Avasarala

Drug Target Insights

Open access

Research article

First published 2022

Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study

Tobias Moser, Ciara O’Sullivan, Ferdinand Otto [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2026

Economic value of anti-CD20 therapies in multiple sclerosis: a systematic review of cost-effectiveness studies

Johannes Heinemann, Marco Zirkel, Oliver Schoeffski [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Other

First published 2010-2

Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients

M. Garcia-Carrasco, C. Mendoza-Pinto, M. Sandoval-Cruz [...]

Lupus

Open access

Research article

First published 2026

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry

Andrea Surcinelli, Tomas Kalincik, Izanne Roos [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Review article

First published 2021-10

Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations

Angelo Ghezzi, Brenda Banwell, Amit Bar-Or [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022-6

Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis

Tatjana Schwarz, Carolin Otto, Terry C Jones [...]

Multiple Sclerosis Journal

Search results